STAAR Surgical Company (STAA) Fair Value 2026 — DCF & Multi-Method Analysis | EvidInvest | EvidInvest

STAA — Fair Value Analysis

STAAR Surgical Company

Current: $24.09Overvalued

Fair Value Range

Bear Case (25th pct.)

$2.13

-91.2% vs price

Base Case (Median)

$2.89

-88.0% vs price

Bull Case (75th pct.)

$3.76

-84.4% vs price

$2.13$2.89$3.76

◇ = Current price | |Bear |Base | Bull

Method Breakdown

Method	Est. Value	vs Price	Weight
DCF (Discounted Cash Flow)	$4.44	-81.6%	High (40%)
PE Comparable	$1.78	-92.6%	Medium (25%)
Growth Trajectory DCF	$2.24	-90.7%	Medium (20%)
Graham Number	$3.54	-85.3%	Medium (40%)

Interpretation

Based on 4 out of 8 methods, STAA appears overvalued at the current price of $24.09. The base case fair value of $2.89 implies 88.0% downside.

Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.